AUY922 has been used in trials studying the treatment of Lymphoma, Breast Cancer, Metastatic Disease, Advanced Solid Tumors, and Hematologic Neoplasms, among others.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.